Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Increasing Prevalence of Heart Disease Drives Growth of Cardiac Biomarkers Diagnostics Market

Published: Monday, April 22, 2013
Last Updated: Sunday, April 21, 2013
Bookmark and Share
Participants need to focus on product customization, ease-of-use and reliability.

Cardiovascular disease (CVD) is the main cause of death in the EU, killing over 2 million people annually and costing the economy nearly €192 billion. Prevention, through constant monitoring of heart health, is seen as the best way to tackle this high death rate.

The most accurate way of monitoring heart health is through cardiac marker testing. Regular monitoring of cardiac health through brain natriuretic peptide (BNP) testing is being practiced across Europe, thereby boosting the cardiac marker testing market.

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Analysis of European Cardiac Biomarkers Diagnostics Market, finds that the market earned revenues of about $607.9 million in 2011 and estimates this to double to reach $1,216.0 million in 2018.

The research covers acute myocardial infarction (AMI) and congestive heart failure (CHF) biomarkers diagnostics.

The increasing role of cardiac markers in patient triaging is further boosting market expansion. Effective implementation of cardiac markers can enable decreased bed occupancy, reduced hospital costs and physician time.

“Cardiac markers rank among the best available tools to assess the patient’s status,” notes Frost & Sullivan Senior Research Analyst K. Srinivas Sashidhar. “For instance, in cases where a test is positive for certain markers, especially cardiac troponin, this would indicate a heart attack. Subsequently, the appropriate treatments and interventions could be administered.”

Due to the urgent nature of myocardial infarction, commonly known as a heart attack, healthcare practitioners have to obtain rapid results for immediate diagnosis and treatment. This need for quick turnaround times has fuelled interest in point-of-care (POC) cardiac testing.

As these trends accelerate market development, saturation will pose a key restraint, especially for the troponin testing segment.

“The troponin testing segment, which now constitutes about a third of the cardiac marker testing market, has reached saturation,” explained Sashidhar. “It is expected to grow slowly, especially in lab-based testing, with growth likely to be mainly through POC testing.”

To sustain market momentum, participants need to develop customized solutions. Multi-menu options for cardiac tests and products that meet market needs, paralleled by alliances with pharmaceutical companies to develop better targeted, therapy-oriented solutions, will keep the market on a growth trajectory.

“Companies need to develop monitoring systems with sufficient product differentiation features to stay competitive,” concluded Sashidhar. “Regardless of the test solution, ease-of-use and reliability will be essential to sustain growth.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Monday, August 24, 2015
Changing Phase of Biomarkers
Discover the current scenario and changing business models of the biomarkers field.
Monday, April 13, 2015
Companion Diagnostics Benefit from Fewer Regulatory Barriers in Europe
Future revisions to in-vitro diagnostics laws will offset the launch of new tests, in a market expected to soar to $1,295.1 million in 2018.
Thursday, June 26, 2014
Personalized Medicine Drives Uptake of Next-generation Sequencing in Europe
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years.
Saturday, May 31, 2014
Emerging Technologies Redefine Infectious Disease Diagnostics
The largest opportunities lie in the developing regions of Asia, Africa and Latin America.
Wednesday, April 23, 2014
Live Cell Imaging Revolutionizes Disease Diagnostics and Drug Discovery
Stakeholder collaboration will be crucial to convert these developments into clinically meaningful tests.
Friday, March 21, 2014
Automated Anatomic Pathology Labs Transform Global Tissue Diagnostics Market
Offering attractive procurement strategies will boost adoption of high-end tools.
Thursday, February 06, 2014
Increasing Public Health Awareness Intensifies Global Uptake of Autoimmune Disease Diagnostics
Frost & Sullivan: Hospitals and laboratories look for cost-effective test panels enabling simultaneous autoimmune diseases testing.
Monday, October 14, 2013
Demand for Rapid Results, Non-invasive Methods and Automated Monitoring Driving the Global POCT Market
Frost & Sullivan finds healthcare infrastructure modernization in developing nations and expanding application scope boosts opportunities for POCT.
Monday, September 30, 2013
High Degree of Disease Prevalence Sustains Diabetes Diagnostics Market in Europe
Companies can increase profits by offering customized testing solutions with accurate, result-oriented features.
Thursday, November 29, 2012
Analysis for Tomorrow's Clinical Approach to Diagnostics, Therapy, Intervention and Monitoring Solutions
As the diverse areas of healthcare forge ahead into overlapping mechanisms and treatments, so too must medical technologies reform to solve several challenges via streamlined remedies.
Thursday, March 22, 2012
Converging towards Integrated Healthcare: A Frost & Sullivan Think Tank on Megatrends Affecting the Healthcare Industry
A clear separation between Medical Devices, Healthcare Technologies and Life Sciences is increasingly difficult. Yet the convergence of all areas opens the door to a new era, enabling personalisation, targeted medicines, new drug delivery mechanisms, and virtual patient monitoring tools, while allowing a preventative approach to healthcare at the same time.
Friday, October 08, 2010
Theranostics Paves the Way for Personalised Medicine in Europe, Says Frost & Sullivan
Strategic Analysis of the European Markets for Theranostics finds that theranostics plays a crucial role in every step of drug development process.
Tuesday, March 23, 2010
Scientific News
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!